Erratum: Shannonhouse et al., “Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca²⁺ Activity of Primary Sensory Neurons in Chemotherapy-Induced Peripheral Neuropathy”

In the article “Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca²⁺ Activity of Primary Sensory Neurons in Chemotherapy-Induced Peripheral Neuropathy,” by John Shannonhouse, Matteo Bernabucci, Ruben Gomez, Hyeonwi Son, Yan Zhang, Chih-Hsuan Ai, Hirotake Ishida, and Yu Shin Kim, which appeared on pages 6020–6037 of the August 3, 2022 issue, some funding information was omitted from the article. NIH 5T32DE014318 was paying author John Shannonhouse's salary and other expenses. The full acknowledgment statement appears below:

This work was supported by National Institutes of Health Grants R01DE026677, R35DE030045, and R01DE031477 (to Y.S.K.), UTHSCSA startup fund (Y.S.K.), a Rising STAR Award from University of Texas system (Y.S.K.), and a Craniofacial Oral-biology Student Training in Academic Research (COSTAR) National Institute of Health Grant T32DE014318 (J.S.).